Physician
The Retina Partners
The Retina Partners was paid $3.06M by Medicaid between Jan 2018 and Nov 2024, across 16 billing codes. Its largest line is 92134, — 30% of everything it billed.
33Billing provider infoTHE RETINA PARTNERS
ENCINO, CA 91436
ENCINO, CA 91436
33aNPI1689945990assigned 01/18/2012
33bProvider typeOphthalmology Physician
28Total paid$3.06M
24GClaims25,242
24DCodes billed16
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#32 of 759
Median peer was paid$35K
This provider vs. median87×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,967 | $223K | |
| 2019 | 4,915 | $511K | |
| 2020 | 3,725 | $530K | |
| 2021 | 3,982 | $617K | |
| 2022 | 3,437 | $501K | |
| 2023 | 3,592 | $396K | |
| 2024incomplete | 2,624 | $286K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92134 | 30% | 10,121 | 9,548 | $931K | |
| J0178 | Injection, aflibercept, 1 mg | 26% | 1,445 | 1,402 | $793K |
| 67028 | Intravitreal injection of a pharmacologic agent | 21% | 6,632 | 6,305 | $635K |
| J2778 | Injection, ranibizumab, 0.1 mg | 12% | 1,096 | 1,050 | $375K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.7% | 1,062 | 1,016 | $114K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3.3% | 1,254 | 1,246 | $100K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 2.9% | 126 | 125 | $88K |
| J7999 | Compounded drug, not otherwise classified | <1% | 584 | 570 | $12K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 100 | 100 | $7K |
| 92250 | <1% | 101 | 101 | $5K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 28 | 28 | $2K |
| 4177F | <1% | 144 | 142 | $2K |
4 more codes
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 822 | $338.15 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 760 | $0.00 |
| 1036F | 0% | 823 | $0.00 | |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 144 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDADGOSTAR, HAJIR (VICE PRESIDENT)